Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
More big trades going through.... ;)
Well, you didn't watch the podcast from the company.
Comments like that make you look silly.
Of course this may or may not have a great deal of impact on Nuvec but it is good news from an organisation N4p have a working relationship with.
Speculation can bring in investment, they wouldn't need to imply there was a direct benefit to them but at least announcing or even posting to congratulate and highlighting the working arrangement with the university that N4p have is something to take advantage of.
Any reason to put out information into the space that investors might see should be grabbed by the horns. It's basic marketing.
i feel that is the main flaw of N4p. Of course trials and testing takes a very long time as it should and results are few and far between but gaining speculative interest is so important in this field.
that's what brought all of us here after all.
Probably a bit premature to suggest Nuvec might see some success in the new RNA lab, Nigel made it crystal clear that Nuvec was behind on its evolution towards clinical trials, unfortunately.
Hopefully we see some evidence that our new asset was a good investment! Happy to be patient and wait this out.
They should have planes writing it in the sky.
but I don't imagine they will bother to tell anyone
Do you think N4P should be sharing this on X or its webpage etc?
Https://stories.uq.edu.au/news/2023/uq-secures-6-6m-to-establish-mrna-lab/index.html
Great news for the team at Queensland University, having the ability to do clinical trials is great for us too.
😂😂😂.
Each morning i have a routine when i get to the office, i log onto my computer, search N4P share price on google, tut, exhale loudly, shake my head then come onto this message board to see if there's any news.
I was pleasantly surprised this morning to see that LSE wasn't the top website in my search but N4 Pharma's own website. I'm hoping this points towards someone working on their search engine optimisation at the very least. or possible a glich. obviously the SP didn't give any pleasant surprises so I'm clutching at any little win i can see
Tempest’s trial showed that its product improved survival in liver cancer when added to two Roche drugs
It was a phase 1b/2 rct with 40 patients from autumn 21 to april23. The multi-centre study was run by Roche
N4p need a large collaborator- a much more advanced product- and one that’s works
It looks like they did DCraig.
Price went from approx 2p down to 0.2p over the course of 2023 before rising on news to 9p at the start of October. Currently 4.25p so still 20 bags from lows.
It would be interesting to know what the success to failure ratio looks like in this sector.
I wonder if their share holders went through a similar period of dismay as we are experiencing
Wow, what a result for Tempest.
Sure shows what can happen in this sector Brighty...!
The rapidly changing nature of the vaccine & oncology treatment markets and the significant opportunity that this presents for siRNA delivery is clearly a massive opportunity for N4P. It was very interesting to note the recent huge rise in Tempest Therapeutics share price, which shot up 3,973% in one day (earlier this month) after results from Tempest's liver cancer trial were unveiled. Tempest Therapeutics, a very small bio with an almost identical MCAP to N4P (£3 million) saw its own market value rise from $3 million to $130 million in just one session. Come on Nigel, we would like a x39 gain for N4P.....
Good luck, Brighty
Nice volume again... lol.
Peak fear levels for N4P?
John077..
Thanks for the context! Wondered what that was about
Mannnan has 59,000 posts with around 59,000 words . Still searching for the word "insight" ;o)
Techtonic, he means instead of N4P, we are now N'1P'. As in valued at approx 1p.
The joke used to be N'4P' when we dropped from the heights down to 4p but obviously 4p seems a good prospect nowadays lol.
down to a penny share now !!!!
still no news on the sirns , last one was in april , awful company, if they had something unique they'd be shouting it from the roof tops !!
they've got nothing to share , obviously all the tests are failing miserably!!!! gone from a 33p to 1p a share in 3 years !!!!! ..... another ceo full of bull**** , taking his wages , and couldn't give a **** about the shareholder !!!!
Oops.."so what exactly had happened now?" I've it's fallen from 30+p, so what's happened today?
You are a man of few words, Mannan, you'll have to explain a little more for my befuddled grey matter
Been share dealing for years, but never heard that one before..N1?
So Mannan..when you said "took longer but it is here"..
What exactly do you mean?
(As in , this share had been c*** for years, do what exactly had happened now?!)
****e share or poorly managed co.
N1 ?
What does that mean?
Shocking really! There's a handful of trades on this today and the sp has plummeted -10%
I refuse to hear "the markets are getting trashed because of the gaza conflict"
N4P has turned into a real dog of a share. What happened to all the wonderful results we are supposed to be having?
I call BS
Took longer but it is here
Watched prezzo again last night.
Importantly, there will (in theory) be double the potential for newflow now.
Given that at 2.5mcap the company is almost priced for failure, there surely cannot be much more downside. Nanogenics needed money to take this project forward and N4 were there to buy in at a discount, taking advantage of their recent weak position and need for a cash injection. Nanogenics had lots of 'discussion' with potential partners but more data is required to move things forward (sounds familiar..!). Nigel seemed confident that future newsflow would result in a higher sp so we will see where the next few months takes N4P.